IP Library Granted Patent US 11,293,022
Granted Patent B2
US 11,293,022 · App. 15/839,820 · Granted Apr 5, 2022

Genome editing enhancement

Inventors: Rolf Turk (Iowa City, IA); Mark A. Behlke (Coralville, IA); Chris Vinci (Evanston, IL)
Assignee: Integrated DNA Technologies, Inc.
C12N15/11C12N9/22C12N9/96C12N15/907C12N15/113C12N2310/20C12N2320/32C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,293,022
App. No.
15/839,820
Granted
Apr 5, 2022
Kind
B2
Abstract

This invention pertains to single-stranded carrier nucleic acids and their methods of use for enhancing genome editing ribonucleoprotein complex transfection into cells and the resulting enhancement of CRISPR editing on the target DNA within those cells, as well as introduction of chemical modifications which reduce the integration of the single-stranded carrier nucleic acids at double-stranded breaks.

Claims (15)

1. A carrier oligonucleotide to improve transfection of ribonucleoprotein (RNP) into a cell in a sample, wherein the carrier oligonucleotide is selected from SEQ ID Nos.: 4, 9, and 25.

2. The carrier oligonucleotide of claim 1 , wherein the carrier oligonucleotide is SEQ ID NO.: 4.

3. The carrier oligonucleotide of claim 1 , wherein the carrier oligonucleotide is SEQ ID NO.: 9.

4. The carrier oligonucleotide of claim 1 , wherein the carrier oligonucleotide is SEQ ID NO.: 25.

5. A method of improving transfection of a ribonucleoprotein into a cell of a sample, comprising:

contacting the cell of the sample with composition having a carrier oligonucleotide,

wherein the carrier oligonucleotide is selected from SEQ ID Nos.: 4, 9, and 25.

6. The method of claim 5 , wherein the concentration of the carrier oligonucleotide in the composition is at least 1 μM.

7. The method of claim 5 , wherein the carrier oligonucleotide is SEQ ID NO.: 4.

8. The method of claim 5 , wherein the carrier oligonucleotide is SEQ ID NO.: 9.

9. The method of claim 5 , wherein the carrier oligonucleotide is SEQ ID NO.: 25.

10. The method of claim 5 , wherein the ribonucleoprotein comprises a Cpf1 ribonucleoprotein.

11. The method of claim 10 , wherein the carrier oligonucleotide comprises SEQ ID No.: 4.

12. The method of claim 10 , wherein the carrier oligonucleotide comprises SEQ ID NO.: 9.

13. The method of claim 10 , wherein the carrier oligonucleotide comprises SEQ ID NO.: 25.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2022
From: TURK, ROLF; BEHLKE, MARK A.; VINCI, CHRIS
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 059647/0703 →
Continuity (2)
Provisional Application 62432950 · Dec 12, 2016
Related Publication 20180273938A1 · Sep 27, 2018